Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy

Journal of Nephrology

Volumn 20, Issue 3, 2007, Pages 320-328

  Nardi, Emilio ^a,b   Cottone, Santina ^a   Mulè, Giuseppe ^a   Palermo, Alessandro ^a   Cusimano, Paola ^a   Cerasola, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Cardiovascular diseases; Chronic renal insufficiency; Diastolic function; Echocardiography; Heart diseases; Hypertension; Left ventricular hypertrophy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENDER; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE REGRESSION; PREDICTION; PULSE PRESSURE;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 35348869249     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-9.
2. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith GL, Coresh J, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcome in the community. J Am Coll Cardiol 2003; 41: 47-55.
3. Manjunath G, Tighiouart H, Coresh J, MacLeod B, Salem DN, Griffith GL, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for cardiovascular outcome in the elderly. Kidney Int 2003; 63: 1121-9.
4. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13: S180-93.
5. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and ecocardiographic disease in patients starting end stage renal disease therapy. Kidney Int 1995; 47: 186-92.
6. Levin A, Thompson C, Ethier J, Carlisle EJF, Tobe S, Mendellsohn D, Burgess E, Jindal K, Barret B, Singer J, Djurdjev O. Left ventricular mass index increase in early renal disease: impact in decline in haemoglobin. Am J Kidney Dis 1999; 34: 125-34.
7. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-31.
8. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002; 40: 1202-10.
9. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4: 1486-90.
10. London GM. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 2001; 16 (Suppl 2): 3-6.
11. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003; 41: S11-7.
12. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 12: 1079-84.
13. London GM. Left ventricular alteration and end-stage renal disease. Nephrol Dial Transplant 2002; 17: 29-36.
14. Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH. Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis 2003; 41: 1016-25.
15. Miyazato J, Horio T, Takiuchl S, Kamide K, Sasaki O, Nakamura S, Nakahama H, Inenaga T, Takishita S, Kawano Y. Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus. Diabet Med 2005; 22: 730-6.
16. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 2004; 65: 1461-6.
17. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
18. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-266.
19. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
20. Sahn DJ, DeMaria A, Kisslo J, Weiman A. The committee on M-mode standardization of the American Society of Echocardiography. Circulation 1978; 58: 1072-3.
21. Devereux RB, Alonso DR, Lutes EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
22. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, De Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol 1992; 20: 1251-60.
23. Skiller N, Shah PM, Crawford M, De Maria A, Devereux RB, Fiegenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
24. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardlography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardlogr 2002; 15: 167-84.
25. De Boeck BW, Cramer MJ, Oh JK, Van der Aa RP, Jaarsma W. Spectral pulsed tissue Doppler imaging in. diastole: a tool to increase our insight in the assessment of diastolic relaxation of the left ventricle. Am Heart J 2003; 146: 411-9.
26. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-92.
27. Choong CY, Herrmann HC, Wayman AE, Fifer MA. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol 1987; 10: 800-8.
28. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, Lee MM, Park JB, Choi YS, Sao JD, Lee YW. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-80.
29. Puleo JA, Aranda JM, Weston MW, Cintron G, French M, Clark L, Fontanet HL. Noninvasive detection of allograft rejection in heart transplant recipients by use of Doppler tissue imaging. J Heart Lung Transplant 1998; 17: 176-84.
30. Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ, Howell JF, Zoghbi WA, Nagueh SF. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 2000; 36: 891-6.
31. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990; 5: 39-44.
32. Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M, Tanimoto S, Amiya E, Hara K. Clinical and pathologic characteristics of dilated cardiomyopathy In hemodialysis patients. Kidney Int 2005; 67: 333-40.
33. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, Fabsitz RR, Howard BW, Devereux RB. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults. The Strong Heart Study. Circulation 2002; 105: 1928-33.
34. Cottone S, Panepinto N, Vadal& A, Zagarrigo C, Galione P, Volpe V, Cerasola G. Sympathetic overactivity and 24-hour blood pressure pattern in hypertensives with chronic renal failure. Ren Fail 1995; 17: 751-8.
35. Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 1993; 71: 12A-16A.
36. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Pro-inflammatory actions of anglotensins. Curr Opin Nephrol Hypertens 2001; 10: 321-9.
37. Roche R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 2002; 970: 89-100.
38. Suzuki Y, Ruiz-Ortega M, Gomez-Guerrero C, Tomino Y, Egido J. Angiotensin II, the immune system and renal disease: another road for RAS? Nephrol Dial Transplant 2003; 18: 1423-6.
39. Chinnaiyan KM, Alexander D, McCullough PA. Role of angiotensin II in the evolution of diastolic heart failure. J Clin Hypertens 2005; 7: 740-7.